Syndicated News

This blog is still in BETA

We are aware of any formatting errors. These stories are automatically pulled from RSS feeds. Due to the automated nature of the post, some images may appear small, and some links may not be clickable until our staff has had the opportunity to manicure the postings. Thank you for understanding.

March 04, 2015

New Hemophilia A Treatment Option to Get FDA Review - Monthly Prescribing Reference

March 04, 2015/

http://ift.tt/1GVJ5mr Click to read full article...

Daily Record

New Hemophilia A Treatment Option to Get FDA ReviewMonthly Prescribing ReferenceThe BLA submission is based on results from the LEOPOLD (Long-Term Efficacy Open-Label Program in Severe Hemophilia A Disease) clinical trials, which evaluated BAY 81-8973 in adults and children using two-and three-times-per-week prophylaxis ...FDA Accepts Bayer's Biologics License Application for Investigational ...PR Newswire (press release)all 4 news articles »

from Hemophilia - Google News http://ift.tt/1GVJ5mr via IFTTT

Committee of Ten Thousand

ADVOCATES FOR PERSONS WITH HIV/AIDS, HEMOPHILIA, HCV, AND SICKLE CELL

MONITORING THE BLOOD SUPPLY AND PROTECTING PATIENT RIGHTS SINCE 1989

The Committee of Ten Thousand is a grass-roots, peer-led, education, advocacy and support organization. The majority of our constituency is persons with hemophilia who contracted HIV/AIDS from tainted blood products. We work in solidarity with all communities affected by the HIV/AIDS pandemic. COTT advocates for disenfranchised chronic disease communities, especially those communities dependent on a safe national blood supply. We are dedicated to the belief that persons with HIV/AIDS and all chronic diseases can lead productive and healthy lives.

Syndicated News

Syndicated News Feed

New Hemophilia A Treatment Option to Get FDA Review - Monthly Prescribing Reference

Committee of Ten Thousand

Quick Links - Sections